| Target Price | $217.26 |
| Price | $265.72 |
| Deviation |
18.24%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target Illumina 2027 .
The average Illumina target price is $217.26.
This is
18.24%
register free of charge
$273.00
2.74%
register free of charge
$114.13
57.05%
register free of charge
|
|
| A rating was issued by 28 analysts: 16 Analysts recommend Illumina to buy, 9 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Illumina stock has an average upside potential 2027 of
18.24%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.34 | 4.71 |
| 0.66% | 8.52% | |
| EBITDA Margin | 26.00% | 28.18% |
| 71.17% | 8.40% | |
| Net Margin | 19.57% | 17.49% |
| 169.97% | 10.64% |
24 Analysts have issued a sales forecast Illumina 2026 . The average Illumina sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Illumina EBITDA forecast 2026. The average Illumina EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Illumina Analysts have issued a net profit forecast 2026. The average Illumina net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 5.45 | 5.46 |
| 170.87% | 0.18% | |
| P/E | 50.15 | |
| EV/Sales | 8.94 |
25 Analysts have issued a Illumina forecast for earnings per share. The average Illumina EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Leerink Partners |
Locked
➜
Locked
|
Locked | Sep 29 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Sep 28 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Argus Research |
Locked
➜
Locked
|
Locked | Sep 03 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Sep 29 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Sep 28 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Argus Research:
Locked
➜
Locked
|
Sep 03 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 03 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


